EMV: We're hitting our targets on-time, and as planned. Our product is already working in multiple stroke centres around the country as we speak. We are on track to crack a multi-billion dollar market with a first and best-in-class device, and are currently consulting with the FDA. Our ratio of SOI vs. MC is absolutely stunning, and there is no CR in sight because we are constantly being funded by private and government grants. What do you guys think?
ASX: Sell.
You gotta wonder sometimes.
Ann: Stage 3 Recuitment Achieved & FDA Engagement Underway, page-14
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$1.74 |
Change
-0.040(2.25%) |
Mkt cap ! $148.7M | |||
| Open | High | Low | Value | Volume |
| $1.78 | $1.78 | $1.74 | $28.44K | 16.11K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 5588 | $1.74 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.79 | 401 | 1 |
View Market Depth
| Last trade - 16.10pm 31/07/2025 (20 minute delay) ? |
| EMV (ASX) Chart |